Jonas Frisén, Chairman
is the Tobias Foundation Professor of Stem Cell Research at the Department of Cell and Molecular Biology, Karolinska Institutet, since 2001. Jonas Frisén is internationally recognized for his studies of stem cells in adult organs. He has received several prestigious awards, was an advisor to the Swedish Government on research and is a member of the Nobel assembly at the Karolinska Institute. He was a founder of NeuroNova AB, a biotech company, which initiated clinical studies with two new pharmaceuticals developed by the company for ALS and Parkinson’s disease, respectively, before being acquired by Newron Pharmaceuticals in 2012.